{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:26:21Z","timestamp":1793820381220,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5756-4","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T16:02:52Z","timestamp":1559577772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-8779","authenticated-orcid":false,"given":"Georgios N.","family":"Tsaousis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Apessos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Agiannitopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Kampouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theofanis","family":"Floros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodoniki","family":"Iosifidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Katopodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Koumarianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Markopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Venizelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Xanthakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Xepapadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeniu","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Tudor","family":"Eniu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serban","family":"Negru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana Lucia","family":"Stanculeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Ungureanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahit","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sualp","family":"Tansan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Tekinel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suayib","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Nasioulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"issue":"38","key":"5756_CR1","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1038\/sj.onc.1207714","volume":"23","author":"R Nagy","year":"2004","unstructured":"Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene. 2004;23(38):6445\u201370.","journal-title":"Oncogene"},{"issue":"2","key":"5756_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2005.10.042","volume":"23","author":"JE Garber","year":"2005","unstructured":"Garber JE, Offit K. Hereditary cancer predisposition syndromes. J Clin Oncol. 2005;23(2):276\u201392.","journal-title":"J Clin Oncol"},{"key":"5756_CR3","first-page":"271","volume":"5","author":"TP Slavin","year":"2015","unstructured":"Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN. Corrigendum: clinical application of multigene panels: challenges of next-generation counseling and Cancer risk management. Front Oncol. 2015;5:271.","journal-title":"Front Oncol"},{"issue":"8","key":"5756_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein LR, Marshall ML, Nusbaum R, Vogel Postula KJ, Weissman SM, Yackowski L, Vaccari EM, Bissonnette J, Booker JK, Cremona ML, et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet Med. 2016;18(8):823\u201332.","journal-title":"Genet Med"},{"issue":"1","key":"5756_CR5","doi-asserted-by":"publisher","first-page":"a002345","DOI":"10.1101\/mcs.a002345","volume":"4","author":"Danielle R. Azzariti","year":"2018","unstructured":"Okur V, Chung WK. The impact of hereditary cancer gene panels on clinical care and lessons learned. Cold Spring Harb Mol Case Stud. 2017;3(6): \n                    https:\/\/doi.org\/10.1101\/mcs.a002345\n                    \n                  .","journal-title":"Molecular Case Studies"},{"issue":"2","key":"5756_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/1099800417750746","volume":"20","author":"KS Price","year":"2018","unstructured":"Price KS, Svenson A, King E, Ready K, Lazarin GA. Inherited Cancer in the age of next-generation sequencing. Biol Res Nurs. 2018;20(2):192\u2013204.","journal-title":"Biol Res Nurs"},{"key":"5756_CR7","unstructured":"The National Comprehensive Cancer Network. \n                    https:\/\/www.nccn.org\n                    \n                  . Accessed 27 Aug 2018."},{"issue":"9","key":"5756_CR8","first-page":"787","volume":"30","author":"JK Plichta","year":"2016","unstructured":"Plichta JK, Griffin M, Thakuria J, Hughes KS. What's new in genetic testing for Cancer susceptibility? Oncology (Williston Park). 2016;30(9):787\u201399.","journal-title":"Oncology (Williston Park)"},{"issue":"13","key":"5756_CR9","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, Hartman AR, Winer EP, Garber JE. Frequency of germline mutations in 25 Cancer susceptibility genes in a sequential series of patients with breast Cancer. J Clin Oncol. 2016;34(13):1460\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5756_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, Kaldate R, Bhatnagar S, Bowles K, Timms K, Garber JE, Herold C, Ellisen L, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121(1):25\u201333.","journal-title":"Cancer"},{"key":"5756_CR11","unstructured":"BRCA Hereditary Cancer MASTR Plus. \n                    https:\/\/www.agilent.com\/en\/products\/next-generation-sequencing\/amplicon-target-amplification-\n                    \n                  (multiplicom)\/cancer-genetics\/brca-hereditary-cancer-mastr-plus. Accessed 27 Aug 2018."},{"issue":"9","key":"5756_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/humu.22825","volume":"36","author":"E Samorodnitsky","year":"2015","unstructured":"Samorodnitsky E, Jewell BM, Hagopian R, Miya J, Wing MR, Lyon E, Damodaran S, Bhatt D, Reeser JW, Datta J, et al. Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing. Hum Mutat. 2015;36(9):903\u201314.","journal-title":"Hum Mutat"},{"issue":"7","key":"5756_CR13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/humu.23237","volume":"38","author":"G Povysil","year":"2017","unstructured":"Povysil G, Tzika A, Vogt J, Haunschmid V, Messiaen L, Zschocke J, Klambauer G, Hochreiter S, Wimmer K. Panelcn.MOPS: copy-number detection in targeted NGS panel data for clinical diagnostics. Hum Mutat. 2017;38(7):889\u201397.","journal-title":"Hum Mutat"},{"issue":"5","key":"5756_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"7616","key":"5756_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285\u201391.","journal-title":"Nature"},{"issue":"7571","key":"5756_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374.","journal-title":"Nature"},{"issue":"22","key":"5756_CR17","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1093\/bioinformatics\/btr540","volume":"27","author":"G Glusman","year":"2011","unstructured":"Glusman G, Caballero J, Mauldin DE, Hood L, Roach JC. Kaviar: an accessible system for testing SNV novelty. Bioinformatics. 2011;27(22):3216\u20137.","journal-title":"Bioinformatics"},{"key":"5756_CR18","unstructured":"Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP), Seattle, WA (URL: \n                    http:\/\/evs.gs.washington.edu\/EVS\/\n                    \n                  ).\u00a0Accessed 27 Aug 2018."},{"issue":"9","key":"5756_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ng.3592","volume":"48","author":"EM Scott","year":"2016","unstructured":"Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, et al. Characterization of greater middle eastern genetic variation for enhanced disease gene discovery. Nat Genet. 2016;48(9):1071\u20136.","journal-title":"Nat Genet"},{"issue":"D1","key":"5756_CR20","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Jang W, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062\u20137.","journal-title":"Nucleic Acids Res"},{"key":"5756_CR21","unstructured":"Online Mendelian Inheritance in Man, OMIM. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). World Wide Web URL: \n                    https:\/\/omim.org\/\n                    \n                  .\u00a0Accessed 27 Aug 2018."},{"issue":"5","key":"5756_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.21438","volume":"32","author":"IF Fokkema","year":"2011","unstructured":"Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011;32(5):557\u201363.","journal-title":"Hum Mutat"},{"issue":"8","key":"5756_CR23","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1093\/hmg\/ddu733","volume":"24","author":"C Dong","year":"2015","unstructured":"Dong C, Wei P, Jian X, Gibbs R, Boerwinkle E, Wang K, Liu X. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum Mol Genet. 2015;24(8):2125\u201337.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"5756_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/jmg.2005.033878","volume":"43","author":"SV Tavtigian","year":"2006","unstructured":"Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, de Silva D, Zharkikh A, Thomas A. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet. 2006;43(4):295\u2013305.","journal-title":"J Med Genet"},{"issue":"1","key":"5756_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1101\/gr.097857.109","volume":"20","author":"KS Pollard","year":"2010","unstructured":"Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20(1):110\u201321.","journal-title":"Genome Res"},{"issue":"12","key":"5756_CR26","doi-asserted-by":"publisher","first-page":"i54","DOI":"10.1093\/bioinformatics\/btp190","volume":"25","author":"M Garber","year":"2009","unstructured":"Garber M, Guttman M, Clamp M, Zody MC, Friedman N, Xie X. Identifying novel constrained elements by exploiting biased substitution patterns. Bioinformatics. 2009;25(12):i54\u201362.","journal-title":"Bioinformatics"},{"key":"5756_CR27","doi-asserted-by":"crossref","unstructured":"The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2017;45(D1):D158\u201369.","DOI":"10.1093\/nar\/gkw1099"},{"issue":"9","key":"5756_CR28","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"FO Desmet","year":"2009","unstructured":"Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37(9):e67.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"5756_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/sim.4116","volume":"30","author":"JT Richardson","year":"2011","unstructured":"Richardson JT. The analysis of 2 x 2 contingency tables--yet again. Stat Med. 2011;30(8):890 author reply 891-892.","journal-title":"Stat Med"},{"issue":"19","key":"5756_CR30","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.2832","volume":"26","author":"I Campbell","year":"2007","unstructured":"Campbell I. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med. 2007;26(19):3661\u201375.","journal-title":"Stat Med"},{"key":"5756_CR31","volume-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2018","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for statistical Computing; 2018."},{"issue":"5","key":"5756_CR32","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.7314\/APJCP.2012.13.5.2051","volume":"13","author":"C Liu","year":"2012","unstructured":"Liu C, Wang QS, Wang YJ. The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2012;13(5):2051\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"5756_CR33","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.7314\/APJCP.2012.13.4.1355","volume":"13","author":"C Liu","year":"2012","unstructured":"Liu C, Wang Y, Wang QS, Wang YJ. The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2012;13(4):1355\u201360.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"5756_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/dna.2013.1970","volume":"32","author":"FF Han","year":"2013","unstructured":"Han FF, Guo CL, Liu LH. The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis. DNA Cell Biol. 2013;32(6):329\u201335.","journal-title":"DNA Cell Biol"},{"issue":"7","key":"5756_CR35","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1158\/1541-7786.MCR-09-0123","volume":"7","author":"F Zhang","year":"2009","unstructured":"Zhang F, Fan Q, Ren K, Andreassen PR. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol Cancer Res. 2009;7(7):1110\u20138.","journal-title":"Mol Cancer Res"},{"issue":"17","key":"5756_CR36","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1073\/pnas.0811159106","volume":"106","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Chen J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci U S A. 2009;106(17):7155\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"5756_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","volume":"19","author":"F Zhang","year":"2009","unstructured":"Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B, Yu X. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol. 2009;19(6):524\u20139.","journal-title":"Curr Biol"},{"issue":"20","key":"5756_CR38","doi-asserted-by":"publisher","first-page":"10312","DOI":"10.1093\/nar\/gks807","volume":"40","author":"R Buisson","year":"2012","unstructured":"Buisson R, Masson JY. PALB2 self-interaction controls homologous recombination. Nucleic Acids Res. 2012;40(20):10312\u201323.","journal-title":"Nucleic Acids Res"},{"issue":"27","key":"5756_CR39","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1074\/jbc.M109.016717","volume":"284","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Zhu Y, Chen J. PALB2 regulates recombinational repair through chromatin association and oligomerization. J Biol Chem. 2009;284(27):18302\u201310.","journal-title":"J Biol Chem"},{"issue":"29","key":"5756_CR40","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1038\/onc.2017.46","volume":"36","author":"TK Foo","year":"2017","unstructured":"Foo TK, Tischkowitz M, Simhadri S, Boshari T, Zayed N, Burke KA, Berman SH, Blecua P, Riaz N, Huo Y, et al. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk. Oncogene. 2017;36(29):4161\u201370.","journal-title":"Oncogene"},{"key":"5756_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13053-017-0083-8","volume":"16","author":"SA Gardner","year":"2018","unstructured":"Gardner SA, Weymouth KS, Kelly WS, Bogdanova E, Chen W, Lupu D, Suhl J, Zeng Q, Geigenmuller U, Boles D, et al. Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory. Hered Cancer Clin Pract. 2018;16:1.","journal-title":"Hered Cancer Clin Pract"},{"issue":"5","key":"5756_CR42","doi-asserted-by":"publisher","first-page":"e0177893","DOI":"10.1371\/journal.pone.0177893","volume":"12","author":"C Evers","year":"2017","unstructured":"Evers C, Fischer C, Dikow N, Schott S. Familial breast cancer: genetic counseling over time, including patients expectations and initiators considering the Angelina Jolie effect. PLoS One. 2017;12(5):e0177893.","journal-title":"PLoS One"},{"key":"5756_CR43","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12885-016-2472-1","volume":"16","author":"C Staudigl","year":"2016","unstructured":"Staudigl C, Pfeiler G, Hrauda K, Renz R, Berger A, Lichtenschopf R, Singer CF, Tea MK. Changes of socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the \u201cAngelina Jolie Effect\u201d. BMC Cancer. 2016;16:436.","journal-title":"BMC Cancer"},{"key":"5756_CR44","unstructured":"The National Comprehensive Cancer Network. Genetic\/Familiar High-Risk Assessment: Breast and Ovarian (Version 2.2019) \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf\n                    \n                  . Accessed 27 Aug 2018."},{"key":"5756_CR45","unstructured":"The National Comprehensive Cancer Network. Genetic\/Familiar High-Risk Assessment: Colorectal (Version 1.2018) \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_colon.pdf\n                    \n                  . Accessed 27 Aug 2018."},{"key":"5756_CR46","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx\n                    \n                  . Accessed 27 Aug 2018."},{"issue":"6","key":"5756_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2174\/138920208785699562","volume":"9","author":"ML Poulsen","year":"2008","unstructured":"Poulsen ML, Bisgaard ML. MUTYH associated polyposis (MAP). Curr Genomics. 2008;9(6):420\u201335.","journal-title":"Curr Genomics"},{"issue":"5","key":"5756_CR48","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1053\/j.gastro.2014.01.022","volume":"146","author":"AK Win","year":"2014","unstructured":"Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG, et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014;146(5):1208\u20131211 e1201-1205.","journal-title":"Gastroenterology"},{"issue":"9","key":"5756_CR49","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/ijc.25870","volume":"129","author":"AK Win","year":"2011","unstructured":"Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC, et al. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer. 2011;129(9):2256\u201362.","journal-title":"Int J Cancer"},{"key":"5756_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2017.10.002","volume":"220","author":"A Apessos","year":"2018","unstructured":"Apessos A, Agiannitopoulos K, Pepe G, Tsaousis GN, Papadopoulou E, Metaxa-Mariatou V, Tsirigoti A, Efstathiadou C, Markopoulos C, Xepapadakis G, et al. Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center. Cancer Genet. 2018;220:1\u201312.","journal-title":"Cancer Genet"},{"issue":"2","key":"5756_CR51","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10549-017-4181-0","volume":"163","author":"B Crawford","year":"2017","unstructured":"Crawford B, Adams SB, Sittler T, van den Akker J, Chan S, Leitner O, Ryan L, Gil E, van \u2018t Veer L. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Breast Cancer Res Treat. 2017;163(2):383\u201390.","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"5756_CR52","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/gim.2014.40","volume":"16","author":"H LaDuca","year":"2014","unstructured":"LaDuca H, Stuenkel AJ, Dolinsky JS, Keiles S, Tandy S, Pesaran T, Chen E, Gau CL, Palmaer E, Shoaepour K, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med. 2014;16(11):830\u20137.","journal-title":"Genet Med"},{"issue":"2","key":"5756_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","volume":"19","author":"SS Kalia","year":"2017","unstructured":"Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249\u201355.","journal-title":"Genet Med"},{"issue":"7","key":"5756_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565\u201374.","journal-title":"Genet Med"},{"issue":"3","key":"5756_CR55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/1389202916666150317232930","volume":"16","author":"HL Blackburn","year":"2015","unstructured":"Blackburn HL, Schroeder B, Turner C, Shriver CD, Ellsworth DL, Ellsworth RE. Management of Incidental Findings in the era of next-generation sequencing. Curr Genomics. 2015;16(3):159\u201374.","journal-title":"Curr Genomics"},{"issue":"3","key":"5756_CR56","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/gim.2017.207","volume":"20","author":"S Macklin","year":"2018","unstructured":"Macklin S, Durand N, Atwal P, Hines S. Observed frequency and challenges of variant reclassification in a hereditary cancer clinic. Genet Med. 2018;20(3):346\u201350.","journal-title":"Genet Med"},{"issue":"2","key":"5756_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41416-018-0127-5","volume":"119","author":"NM Tung","year":"2018","unstructured":"Tung NM, Garber JE. BRCA1\/2 testing: therapeutic implications for breast cancer management. Br J Cancer. 2018;119(2):141\u201352.","journal-title":"Br J Cancer"},{"issue":"4","key":"5756_CR58","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1470-2045(15)70064-1","volume":"16","author":"XC Hu","year":"2015","unstructured":"Hu XC, Zhang J, Xu BH, Cai L, Ragaz J, Wang ZH, Wang BY, Teng YE, Tong ZS, Pan YY, et al. Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial. Lancet Oncol. 2015;16(4):436\u201346.","journal-title":"Lancet Oncol"},{"issue":"6","key":"5756_CR59","first-page":"286","volume":"133","author":"JA Brakenhoff","year":"1989","unstructured":"Brakenhoff JA, Bakker PJ, Veenhof CH. Side effects of cytostatic agents; treatment recommendations. Ned Tijdschr Geneeskd. 1989;133(6):286\u20139.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"5756_CR60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1535-7163.MCT-10-0893","volume":"10","author":"MC Villarroel","year":"2011","unstructured":"Villarroel MC, Rajeshkumar NV, Garrido-Laguna I, De Jesus-Acosta A, Jones S, Maitra A, Hruban RH, Eshleman JR, Klein A, Laheru D, et al. Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol Cancer Ther. 2011;10(1):3\u20138.","journal-title":"Mol Cancer Ther"},{"key":"5756_CR61","unstructured":"U.S. Food and Drug Administration (FDA). \n                    https:\/\/www.fda.gov\n                    \n                  . Accessed 27 Aug 2018."},{"issue":"5","key":"5756_CR62","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/path.5025","volume":"244","author":"K Nesic","year":"2018","unstructured":"Nesic K, Wakefield M, Kondrashova O, Scott CL, McNeish IA. Targeting DNA repair: the genome as a potential biomarker. J Pathol. 2018;244(5):586\u201397.","journal-title":"J Pathol"},{"issue":"9","key":"5756_CR63","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1158\/2159-8290.CD-17-0419","volume":"7","author":"O Kondrashova","year":"2017","unstructured":"Kondrashova O, Nguyen M, Shield-Artin K, Tinker AV, Teng NNH, Harrell MI, Kuiper MJ, Ho GY, Barker H, Jasin M, et al. Secondary somatic mutations restoring RAD51C and RAD51D associated with acquired resistance to the PARP inhibitor Rucaparib in high-grade ovarian carcinoma. Cancer Discov. 2017;7(9):984\u201398.","journal-title":"Cancer Discov"},{"issue":"1","key":"5756_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1470-2045(16)30559-9","volume":"18","author":"EM Swisher","year":"2017","unstructured":"Swisher EM, Lin KK, Oza AM, Scott CL, Giordano H, Sun J, Konecny GE, Coleman RL, Tinker AV, O'Malley DM, et al. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 part 1): an international, multicentre, open-label, phase 2 trial. Lancet Oncol. 2017;18(1):75\u201387.","journal-title":"Lancet Oncol"},{"issue":"18","key":"5756_CR65","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","volume":"373","author":"J Mateo","year":"2015","unstructured":"Mateo J, Carreira S, Sandhu S, Miranda S, Mossop H, Perez-Lopez R, Nava Rodrigues D, Robinson D, Omlin A, Tunariu N, et al. DNA-repair defects and Olaparib in metastatic prostate Cancer. N Engl J Med. 2015;373(18):1697\u2013708.","journal-title":"N Engl J Med"},{"issue":"3","key":"5756_CR66","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","volume":"20","author":"KP Pennington","year":"2014","unstructured":"Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH, Thornton A, Norquist BM, Casadei S, Nord AS, et al. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res. 2014;20(3):764\u201375.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"5756_CR67","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","volume":"66","author":"N McCabe","year":"2006","unstructured":"McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O'Connor MJ, Tutt AN, Zdzienicka MZ, et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res. 2006;66(16):8109\u201315.","journal-title":"Cancer Res"},{"issue":"5","key":"5756_CR68","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1128\/MCB.21.5.1828-1832.2001","volume":"21","author":"J Menisser-de Murcia","year":"2001","unstructured":"Menisser-de Murcia J, Mark M, Wendling O, Wynshaw-Boris A, de Murcia G. Early embryonic lethality in PARP-1 Atm double-mutant mice suggests a functional synergy in cell proliferation during development. Mol Cell Biol. 2001;21(5):1828\u201332.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"5756_CR69","doi-asserted-by":"publisher","first-page":"a002154","DOI":"10.1101\/mcs.a002154","volume":"3","author":"Volkan Okur","year":"2017","unstructured":"Azzariti DR, Riggs ER, Niehaus A, Rodriguez LL, Ramos EM, Kattman B, Landrum MJ, Martin CL, Rehm HL. Points to consider for sharing variant-level information from clinical genetic testing with ClinVar. Cold Spring Harb Mol Case Stud. 2018;4(1): \n                    https:\/\/doi.org\/10.1101\/mcs.a002154\n                    \n                  .","journal-title":"Molecular Case Studies"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5756-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5756-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T23:51:43Z","timestamp":1591055503000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5756-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5756"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5756-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"3 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All tested individuals provided a signed informed consent form prior to molecular genetic testing and permission for the anonymous use of their data for research purposes and\/or scientific publications. The study was approved by the ethics committee of Hellenic Breast Surgeons Society.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"535"}}